Prosemble has been awarded funding through the Innovate UK Biomedical Catalyst (BMC) Femtech & AI in Health: Feasibility Competition 2025. The grant will support research into targeted drug delivery for EGFR-positive lung cancer using protein nanoparticles and...

Inna Zhuranskaya attended Supercharging Innovation in AI, Data Science, and Health Care, which brought together leaders from government, academia, and industry to explore how the UK can accelerate innovation in health care. The event featured welcome remarks from...

On 10 October, Inna Zhuranskaya attended the TCS Good Growth Event in collaboration with Exponent Women. This year marks the fifth anniversary of the event — a milestone celebration bringing together leaders, investors, and innovators to discuss growth, technology,...

Inna Zhuranskaya attended the HSBC Innovation Banking Oncology Innovation Day, which brought together venture investors, pharmaceutical leaders, innovators, government representatives, and other industry thought leaders. Notable speakers included: Steve Bates OBE...

The Prosemble team recently attended the Pioneer Group Summer Graduate Soirée, an event celebrating innovation, networking, and collaboration across the life sciences and technology sectors. During the event, team members met with: Tiffany Thorn, Founder & CEO of...

We’re delighted to announce a significant expansion of the Prosemble team as we continue to grow our capabilities across both AI and life sciences. Please join us in welcoming our newest colleagues and consultants: Tamara Veres – AI/Bioinformatics Specialist (Dry Lab)...